Trial · NCT01154166
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Total Awake Time Spent Off at Week 24 Using Last Observation Carried Forward (LOCF) | Placebo | -0.4 | Standard Deviation 2.47 | hours | |
| Mean Change From Baseline in Total Awake Time Spent Off at Week 24 Using Last Observation Carried Forward (LOCF) | Ropinirole PR | -2.1 | Standard Deviation 2.58 | hours | |
| Mean Change From Baseline (BL) in the Unified Parkinson Disease Rating Scale (UPDRS) Total Motor Score at Week 24 Using LOCF | Placebo | -0.7 | Standard Deviation 9.03 | scores on a scale | |
| Mean Change From Baseline (BL) in the Unified Parkinson Disease Rating Scale (UPDRS) Total Motor Score at Week 24 Using LOCF | Ropinirole PR | -6.3 | Standard Deviation 10.08 | scores on a scale | |
| Mean Change From Baseline in the Percentage of Awake Time Spent Off (ATSO) at Week 24 Using LOCF | Placebo | -1.8 | Standard Deviation 15.88 | Percentage of time | |
| Mean Change From Baseline in the Percentage of Awake Time Spent Off (ATSO) at Week 24 Using LOCF | Ropinirole PR | -13.5 | Standard Deviation 15.62 | Percentage of time | |
| Mean Change From Baseline in Total Awake Time Spent on at Week 24 Using LOCF | Placebo | 0.1 | Standard Deviation 2.48 | hours | |
| Mean Change From Baseline in Total Awake Time Spent on at Week 24 Using LOCF | Ropinirole PR | 1.9 | Standard Deviation 2.44 | hours | |
| Mean Change From Baseline in Total Awake Time on Without Troublesome Dyskinesias (TD) at Week 24 Using LOCF | Placebo | 0.3 | Standard Deviation 2.56 | hours | |
| Mean Change From Baseline in Total Awake Time on Without Troublesome Dyskinesias (TD) at Week 24 Using LOCF | Ropinirole PR | 1.7 | Standard Deviation 2.81 | hours | |
| Mean Change From Baseline in the UPDRS Activities of Daily Living (ADL) Score at Week 24 Using LOCF | Placebo | -0.2 | Standard Deviation 3.64 | scores on a scale | |
| Mean Change From Baseline in the UPDRS Activities of Daily Living (ADL) Score at Week 24 Using LOCF | Ropinirole PR | -2.2 | Standard Deviation 3.93 | scores on a scale | |
| Number of Responders Based on the Clinical Global Impression (CGI) Global Improvement Scale Using LOCF | Placebo | 16 | participants | ||
| Number of Responders Based on the Clinical Global Impression (CGI) Global Improvement Scale Using LOCF | Ropinirole PR | 77 | participants | ||
| Number of Participants Requiring Reinstatement of L-dopa Following a Dose Reduction Using LOCF | Placebo | 23 | participants | ||
| Number of Participants Requiring Reinstatement of L-dopa Following a Dose Reduction Using LOCF | Ropinirole PR | 13 | participants | ||
| Number of Responders to Study Treatment Using LOCF | Placebo | 4 | participants | ||
| Number of Responders to Study Treatment Using LOCF | Ropinirole PR | 39 | participants | ||
| Mean Change From Baseline in the Depression Scores on the Hamilton Depression Rating Scale (HAMD-17) Using LOCF | Placebo | -0.6 | Standard Deviation 4.33 | scores on a scale | |
| Mean Change From Baseline in the Depression Scores on the Hamilton Depression Rating Scale (HAMD-17) Using LOCF | Ropinirole PR | -1.6 | Standard Deviation 4.38 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01154166/results